AVDL250117P7500
- 0.10
- -0.22-68.75%
Avadel Pharmaceuticals Newsroom
Avadel Pharmaceuticals Analyst Ratings
Needham Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $19
Analysts Conflicted on These Healthcare Names: Avadel Pharmaceuticals (AVDL) and ACADIA Pharmaceuticals (ACAD)
Stocks to Watch: Avadel Pharmaceuticals, Siyata Mobile, Liberty Media
Avadel Sees Narcolepsy Drug Fueling Earnings Growth
Avadel Pharmaceuticals Projects Robust Growth for LUMRYZ
Avadel Pharmaceuticals Preliminary Q4 Net Product Revenue Rises; 2025 Outlook Set; Shares Fall After Hours
Avadel Pharma: Positive Cash Flow in 4Q Ending With About $73M of Cash, Cash Equivalents and Marketable Securities >AVDL
Avadel Pharmaceuticals Sees 2025 LUMRYZ Net Pdt Rev of $240 - $260 M >AVDL
Avadel Pharmaceuticals Sees Prelim. Q4 Revenue ~$50.0M Vs $52.312M Est.
Express News | Avadel Pharmaceuticals Sees Prelim. Q4 Revenue ~$50.0M Vs $52.312M Est
Express News | Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
C-Suite Buy of the Week: Unusual Insider Trading Trends as 2025 Approaches
Several Insiders Invested In Avadel Pharmaceuticals Flagging Positive News
Independent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More Stock
Avadel Pharmaceuticals Announces Publication of Findings on Sodium Oxybate
Avadel Pharmaceuticals Presents Results From Social Listening Analysis And Survey Of People With Narcolepsy Uncover Real-Life Challenges With Twice-Nightly Oxybate Therapy
Insider Purchase: Director at $AVDL (AVDL) Buys 3,000 Shares